Marshall Wace, LLP Annexon, Inc. Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Annexon, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 29,989 shares of ANNX stock, worth $95,065. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,989Holding current value
$95,065% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding ANNX
# of Institutions
136Shares Held
96.4MCall Options Held
0Put Options Held
63.4K-
Satter Management Co., L.P.7.41MShares$23.5 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$22.2 Million0.66% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$20.9 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$20 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$17 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $151M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...